Risk Groups for Survival in HPV-positive and HPV-negative HNSCC

Autor: Rietbergen, MM, Brakenhoff, RH, Leemans, CR

Publikováno v: Rietbergen, MM, Brakenhoff, RH & Leemans, CR 2016, Risk Groups for Survival in HPV-positive and HPV-negative HNSCC . in HPV Infection in Head and Neck Cancer . Springer International Publishing, pp. 221-232 .
HPV Infection in Head and Neck Cancer, 221-232
STARTPAGE=221;ENDPAGE=232;TITLE=HPV Infection in Head and Neck Cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::19b1115f44744020bf2f4a8142c60ad9
https://research.vumc.nl/en/publications/5adb1c6f-5498-4da3-96db-f7f3fc1ddb16

Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.

Autor: Rietbergen MM; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Cancer Center Amsterdam, The Netherlands., van Bokhoven AAJD; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Cancer Center Amsterdam, The Netherlands., Lissenberg-Witte BI; Department of Epidemiology and Biostatistics, VU University Medical Center, Cancer Center Amsterdam, The Netherlands., Heideman DAM; Department of Pathology, VU University Medical Center, Cancer Center Amsterdam, The Netherlands., Leemans CR; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Cancer Center Amsterdam, The Netherlands., Brakenhoff RH; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Cancer Center Amsterdam, The Netherlands., Bloemena E; Department of Pathology, VU University Medical Center, Cancer Center Amsterdam, The Netherlands.; Department of Oral and Maxillofacial Surgery/Oral Pathology, VU University Medical Center/Academic Center for Dentistry Amsterdam (ACTA), The Netherlands.

Publikováno v: International journal of cancer [Int J Cancer] 2018 Jul 15; Vol. 143 (2), pp. 283-288. Date of Electronic Publication: 2018 Mar 02.

Corrigendum to "Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging" [Radiother Oncol 113 (2014) 324-30].

Autor: Velazquez ER; Department of Radiation Oncology (MAASTRO), Research Institute GROW, Maastricht University, Maastricht, The Netherlands., Hoebers F; Department of Radiation Oncology (MAASTRO), Research Institute GROW, Maastricht University, Maastricht, The Netherlands. Electronic address: frank.hoebers@maastro.nl., Aerts HJWL; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, USA., Rietbergen MM; Department of Otolaryngology - Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands., Brakenhoff RH; Department of Otolaryngology - Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands., Leemans RC; Department of Otolaryngology - Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands., Speel EJ; Department of Pathology, Maastricht University Medical Centre+, The Netherlands., Straetmans J; Department of Otolaryngology - Head and Neck Surgery, Maastricht University Medical Centre+, The Netherlands., Kremer B; Department of Otolaryngology - Head and Neck Surgery, Maastricht University Medical Centre+, The Netherlands., Lambin P; Department of Radiation Oncology (MAASTRO), Research Institute GROW, Maastricht University, Maastricht, The Netherlands.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2017 Aug; Vol. 124 (2), pp. 337-338. Date of Electronic Publication: 2017 Jul 11.

Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer.

Autor: Parmar C; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School , Boston, MA , USA ; Department of Radiology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School , Boston, MA , USA ; Radiation Oncology (MAASTRO), Research Institute GROW, Maastricht University , Maastricht , Netherlands., Grossmann P; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School , Boston, MA , USA ; Department of Radiology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School , Boston, MA , USA ; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute , Boston, MA , USA., Rietveld D; Department of Radiation Oncology, VU University Medical Center , Amsterdam , Netherlands., Rietbergen MM; Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center , Amsterdam , Netherlands., Lambin P; Radiation Oncology (MAASTRO), Research Institute GROW, Maastricht University , Maastricht , Netherlands., Aerts HJ; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School , Boston, MA , USA ; Department of Radiology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School , Boston, MA , USA ; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute , Boston, MA , USA.

Publikováno v: Frontiers in oncology [Front Oncol] 2015 Dec 03; Vol. 5, pp. 272. Date of Electronic Publication: 2015 Dec 03 (Print Publication: 2015).

Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe.

Autor: Rietbergen MM; Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands., Witte BI; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands., Velazquez ER; Department of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands., Snijders PJ; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Bloemena E; Department of Oral and Maxillofacial Surgery/Oral Pathology, VU University Medical Center/Academic Center for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands., Speel EJ; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands., Brakenhoff RH; Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands., Kremer B; Department of Otolaryngology/Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands., Lambin P; Department of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands., Leemans CR; Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands.

Publikováno v: British journal of cancer [Br J Cancer] 2015 May 26; Vol. 112 (11), pp. 1733-6. Date of Electronic Publication: 2015 May 07.